the role of rna modifications in mds and aml
Published 1 year ago • 44 plays • Length 0:55Download video MP4
Download video MP3
Similar videos
-
3:10
the role of ngs in mds diagnosis
-
1:09
the changing role of allosct in dlbcl in the era of novel agents
-
1:52
advances in lr-mds and hr-mds in 2023 and beyond
-
1:16
state of the art: mds
-
2:04
state-of-the-art treatment for hr-mds
-
1:43
exploring the role of non-coding rnas in cll biology
-
2:33
insights into the results and implications of the commands & imerge studies in lr-mds
-
1:55
diagnosing and treating aml: the role of mutational profiling
-
23:31
reading the first draft of my book! 📖 | writing vlog ✍🏼 | nanowrimo
-
2:01
rna n-6-methyladenosine modifications in cells and tissues | protocol preview
-
8:01
lncrnalyzr: lncrna enrichment analysis app
-
3:37
progress in the categorization and treatment of lr-mds
-
1:39
update on a phase i/ii study of ziftomenib in patients with r/r aml
-
1:34
sequencing of agents in lr-mds
-
2:08
hematological response to frontline treatment in lr-mds is associated with better os
-
1:13
the main treatment goals in lr-mds and how these differ from hr-mds
-
1:16
how novel immunotherapies have impacted the treatment of r/r all
-
1:03
the growing importance of single-cell rna sequencing in hematology
-
3:23
final long-term follow-up results of the relaza2 study: mrd-guided treatment with aza in mds and aml
-
2:52
long-term evaluation of luspatercept in esa-intolerant/refractory lr-mds: medalist follow-up study
-
2:29
the role of the multidisciplinary team in providing adequate diagnosis & treatment for bpdcn
-
2:59
low-intensity venetoclax-based preconditioning followed by sequential allosct for r/r aml or hr-mds